CSIMarket
 


Establishment Labs Holdings Inc   (ESTA)
Other Ticker:  
 

Cumulative Establishment Labs Holdings Inc 's Leverage Ratio for Trailing Twelve Months Period

ESTA's Leverage Ratio for Trailing Twelve Months Period and Total Liabilities, Equity growth


Select the Comparisons : Select the Ratio:

ESTA Leverage Ratio for Trailing Twelve Months Period

(Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Equity Growth - 1907.04 % 245.83 % - -
Y / Y Total Liabilities Growth 509.91 % 29.71 % 24.66 % 141.46 % -53.29 %
Leverage Ratio for Trailing Twelve Months Period 10.64 11.88 20.88 - 8.72
Total Ranking # 2559 # 3925 # 4174 # # 4659
Seq. Equity Growth -39.66 % -44.44 % - - -
Seq. Total Liabilities Growth 4.39 % 4.35 % 2.39 % 446.85 % -77.8 %


Leverage Ratio for Trailing Twelve Months Period Comment for 12 Months ending at Dec 31 2023
On the trailing twelve months basis Despite net new borrowings of 4.39% Establishment Labs Holdings Inc managed to decrease Leverage Ratio for Trailing Twelve Months Period in IV. Quarter to 10.64, above Establishment Labs Holdings Inc 's average Leverage Ratio for Trailing Twelve Months Period.
Leverage Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies in Medical Equipment & Supplies industry 121 other companies have achieved lower Leverage Ratio for Trailing Twelve Months Period than Establishment Labs Holdings Inc . While total ranking remained unchanged compare to previous quarter at no. .

What is Leverage Ratio?
Who are ESTA's Customers?
Leverage Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 122
Sector # 436
S&P 500 # 2628


Leverage Ratio for Trailing Twelve Months Period Statistics
High Average Low
26.73 5.5 0.95
(Jun 30 2023)   (Dec 31 2020)




Companies with similar average Leverage Ratio for Trailing Twelve Months Period for 12 months ending Dec 31 2023, within Medical Equipment & Supplies Industry Leverage Ratio for Trailing Twelve Months Period
Carmell Corporation  28.26 
Harpoon Therapeutics Inc   23.43 
Motus Gi Holdings Inc   14.79 
P3 Health Partners Inc   9.66 
Marizyme Inc   9.60 
Biolase Inc   7.49 
The Beauty Health Company  7.32 
Accuray Incorporated  7.21 
Invacare Holdings Corporation  7.03 
Mimedx Group Inc   6.10 
Delcath Systems Inc   5.23 
Owens and Minor inc  4.39 
3m Company  3.80 
Yunhong Green Cti Ltd   3.75 
Plus Therapeutics Inc   3.45 
Tela Bio Inc   3.37 
Insulet Corporation  3.13 
Biosig Technologies Inc   3.09 
Baxter International Inc   3.07 
Polypid Ltd   3.04 
Neuropace Inc   3.01 
The Pennant Group Inc   2.89 
Bioventus Inc   2.83 
Petvivo Holdings Inc  2.72 
Viewray Inc   2.67 
Cerus Corporation  2.63 
Vivos Therapeutics Inc   2.47 
Apollo Endosurgery inc   2.38 
Uphealth Inc   2.35 
Pulse Biosciences Inc   2.27 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com